Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSPC PHARMA

7.730
-0.090-1.15%
Volume:124.28M
Turnover:959.16M
Market Cap:89.04B
PE:19.15
High:7.890
Open:7.820
Low:7.620
Close:7.820
Loading ...

CSPC Pharmaceutical Group Ltd. Announces Appointment of Ms. LI Quan to Nomination Committee

Reuters
·
27 Jun

CSPC Pharmaceutical Group Stock Falls 1.9% in Hong Kong, Underperforms Competitors

Dow Jones
·
26 Jun

CSPC Pharmaceutical Group Expands Subsidiary Operations in China

Reuters
·
24 Jun

CSPC Pharmaceutical Group Ltd. Secures Drug Registration Approval for Meloxicam Injection (III) in China

Reuters
·
23 Jun

CSPC Pharmaceutical - Meloxicam Injection Obtains Drug Registration Approval

THOMSON REUTERS
·
23 Jun

CSPC Pharmaceutical Group Ltd. Files Next Day Disclosure Return to HKEX: Announces 500,000 New Shares Issued at HKD 5.98

Reuters
·
20 Jun

Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$10.22 From HK$8.02, Keeps at Buy

MT Newswires Live
·
16 Jun

CSPC Pharmaceutical Set to Benefit From AstraZeneca Agreement -- Market Talk

Dow Jones
·
16 Jun

CSPC Pharmaceutical Group Signs Strategic Collaboration with AstraZeneca for Drug Discovery

Reuters
·
13 Jun

BRIEF-Astrazeneca Enters Collaboration Worth Up To $5.22 Bln With CSPC Pharmaceuticals

Reuters
·
13 Jun

CSPC Pharmaceutical - Group Will Receive an Upfront Payment of US$110 Mln

THOMSON REUTERS
·
13 Jun

CSPC Pharmaceutical - Agreement for Discovery and Development of Novel Oral Small Molecule Candidates

THOMSON REUTERS
·
13 Jun

CSPC Pharmaceutical - Also Eligible to Receive up to US$1,620 Mln in Potential Development Milestone Payments

THOMSON REUTERS
·
13 Jun

AstraZeneca Plc - to Have Rights for Exclusive Licenses Under Agreement

THOMSON REUTERS
·
13 Jun

BRIEF-Cspc Pharmaceutical's Sys6040 Obtains Clinical Trial Approval In U.S.

Reuters
·
10 Jun

CSPC Pharmaceutical Group Ltd. Receives U.S. FDA Approval for Clinical Trials of SYS6040 Antibody-Drug Conjugate Targeting Advanced Solid Tumors

Reuters
·
10 Jun

CSPC Pharmaceutical - Sys6040 Obtains Clinical Trial Approval in U.S.

THOMSON REUTERS
·
10 Jun

CSPC Pharmaceutical Gets China Nod for Registration of Anemia Drug

MT Newswires Live
·
05 Jun

CSPC Pharmaceutical Group Ltd. Secures Drug Registration Approval for Cobamamide Capsules in China

Reuters
·
05 Jun

CSPC Pharmaceutical - Cobamamide Capsules Obtain Drug Registration Approval From Nmpa

THOMSON REUTERS
·
05 Jun